These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18188499)

  • 1. PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease.
    Chan DK; Mok V; Ng PW; Yeung J; Kwok JB; Fang ZM; Clarke R; Wong L; Schofield PR; Hattori N
    J Neural Transm (Vienna); 2008 May; 115(5):715-9. PubMed ID: 18188499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.
    Huang T; Gao CY; Wu L; Gong PY; Wang JZ; Tian YY; Zhang YD
    Brain Behav; 2019 Sep; 9(9):e01372. PubMed ID: 31386307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel compound heterozygous mutations in the
    Shi Y; Kawakami H; Zang W; Li G; Zhang J; Xu C
    Brain Behav; 2018 Jan; 8(1):e00901. PubMed ID: 29568695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease: A case report.
    Fang YQ; Mao F; Zhu MJ; Li XH
    Medicine (Baltimore); 2019 Feb; 98(5):e14228. PubMed ID: 30702579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.
    Monroy-Jaramillo N; Guerrero-Camacho JL; Rodríguez-Violante M; Boll-Woehrlen MC; Yescas-Gómez P; Alonso-Vilatela ME; López-López M
    Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):235-44. PubMed ID: 24677602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
    Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
    J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease.
    Kim SY; Seong MW; Jeon BS; Kim SY; Ko HS; Kim JY; Park SS
    Clin Genet; 2012 Jul; 82(1):77-82. PubMed ID: 21534944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of PARK2 in a Uyghur family with early-onset Parkinson's disease in Xinjiang, China.
    Li H; Yusufujiang A; Naser S; Zhu Y; Maimaiti M; He X; Bu J; Meng X; Wang M; Li J; Dina B; Yang L; Nayi Z; Dang H; Wang C; Amiti D; Aji A; Yusufu N; Jiao Y; Duan F
    J Neurol Sci; 2014 Jul; 342(1-2):21-4. PubMed ID: 24831986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.
    Hertz JM; Ostergaard K; Juncker I; Pedersen S; Romstad A; Møller LB; Güttler F; Dupont E
    Eur J Neurol; 2006 Apr; 13(4):385-90. PubMed ID: 16643317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.
    Ben-Shachar S; Afawi Z; Masalha R; Badarny S; Neiman T; Pavzner D; Bar-Shira A; Orr-Urtreger A
    J Mol Neurosci; 2017 Oct; 63(2):216-222. PubMed ID: 28913705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients.
    Koziorowski D; Hoffman-Zacharska D; Sławek J; Jamrozik Z; Janik P; Potulska-Chromik A; Roszmann A; Tataj R; Bal J; Friedman A
    Neurol Neurochir Pol; 2013; 47(4):319-24. PubMed ID: 23986421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARK2 gene mutations in early onset Parkinson's disease patients of South India.
    Padmaja MV; Jayaraman M; Srinivasan AV; Srisailapathy CR; Ramesh A
    Neurosci Lett; 2012 Aug; 523(2):145-7. PubMed ID: 22766139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic study of a Parkinson's disease pedigree caused by compound heterozygous mutations in PARK2 gene].
    Chen M; Cen Z; Chen Y; Zheng X; Xie F; Chen S; Luo W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Dec; 35(6):815-818. PubMed ID: 30512153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.
    Kilarski LL; Pearson JP; Newsway V; Majounie E; Knipe MD; Misbahuddin A; Chinnery PF; Burn DJ; Clarke CE; Marion MH; Lewthwaite AJ; Nicholl DJ; Wood NW; Morrison KE; Williams-Gray CH; Evans JR; Sawcer SJ; Barker RA; Wickremaratchi MM; Ben-Shlomo Y; Williams NM; Morris HR
    Mov Disord; 2012 Oct; 27(12):1522-9. PubMed ID: 22956510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole exome sequencing identified a new compound heterozygous PRKN mutation in a Chinese family with early-onset Parkinson's disease.
    Li T; Kou D; Cui Y; Le W
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.
    Sun M; Latourelle JC; Wooten GF; Lew MF; Klein C; Shill HA; Golbe LI; Mark MH; Racette BA; Perlmutter JS; Parsian A; Guttman M; Nicholson G; Xu G; Wilk JB; Saint-Hilaire MH; DeStefano AL; Prakash R; Williamson S; Suchowersky O; Labelle N; Growdon JH; Singer C; Watts RL; Goldwurm S; Pezzoli G; Baker KB; Pramstaller PP; Burn DJ; Chinnery PF; Sherman S; Vieregge P; Litvan I; Gillis T; MacDonald ME; Myers RH; Gusella JF
    Arch Neurol; 2006 Jun; 63(6):826-32. PubMed ID: 16769863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients.
    Aguiar Pde C; Lessa PS; Godeiro C; Barsottini O; Felício AC; Borges V; Silva SM; Saba RA; Ferraz HB; Moreira-Filho CA; Andrade LA
    Mov Disord; 2008 Jul; 23(9):1228-33. PubMed ID: 18464276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel parkin mutations detected in patients with early-onset Parkinson's disease.
    Bertoli-Avella AM; Giroud-Benitez JL; Akyol A; Barbosa E; Schaap O; van der Linde HC; Martignoni E; Lopiano L; Lamberti P; Fincati E; Antonini A; Stocchi F; Montagna P; Squitieri F; Marini P; Abbruzzese G; Fabbrini G; Marconi R; Dalla Libera A; Trianni G; Guidi M; De Gaetano A; Boff Maegawa G; De Leo A; Gallai V; de Rosa G; Vanacore N; Meco G; van Duijn CM; Oostra BA; Heutink P; Bonifati V;
    Mov Disord; 2005 Apr; 20(4):424-431. PubMed ID: 15584030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of PARK2 and PINK1 genes in Brazilian patients with early-onset Parkinson's disease.
    Moura KC; Campos Junior M; de Rosso AL; Nicaretta DH; Pereira JS; Silva DJ; dos Santos FL; Rodrigues Fda C; Santos-Rebouças CB; Pimentel MM
    Dis Markers; 2013; 35(3):181-5. PubMed ID: 24167364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parkinson's disease associated with a mutation in the PARK2 gene].
    Kaasinen V; Hietala M; Kuoppamäki M
    Duodecim; 2015; 131(12):1187-90. PubMed ID: 26245049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.